4TO.F MAINZ BIOMED B.V. EO 1

Healthcare Biotechnology Frankfurt Exchange
0.2000 EUR
Close of Nov 11, 2026
8.00 8.00
Market cap
EUR 17.4M
P/E
-
P/B
1.72x
ROE
-158.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4TO.F undervalued?

Graham number

The Graham number of MAINZ BIOMED B.V. EO 1 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MAINZ BIOMED B.V. EO 1 fundamental analysis

No fundamental analysis for MAINZ BIOMED B.V. EO 1 yet.

MAINZ BIOMED B.V. EO 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MAINZ BIOMED B.V. EO 1

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones,…

Full company profile